| Name | Title | Contact Details |
|---|
Cyanotech Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kailua Kona, HI. To find more information about Cyanotech Corporation, please visit www.cyanotech.com
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Theorem Clinical Research is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cadence Science is a New Hyde Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Together, making health care better for our communities.Setting a new standard in patient care excellence. Hospitals in the Capella Healthcare family will be the center point for transforming the quality of life in their communities, focusing first on improving the health and well-being of every individual.